Sharemaestro company-news research for Almonty Industries Inc. (ALI1), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

GER Germany Provisional evidence

Company news sentiment

ALI1 news sentiment

Almonty Industries Inc.

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

Full chart Weekly report Factor research RSS feed
30-day score49Neutral is 50
Early balanced news score 29/100 evidence confidence 100% direct company focus 11 current stories across 7 publishers
Latest weekly closeEUR 12.04week of 7 Aug 2026
Main news subjectMarket update89/100 share of current news
News data statusHealthy0 duplicate stories removed

Current company news

Early balanced news score

11 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.

Observed headline tone47/100 Reliability-adjusted score49/100

Freshness, source quality and evidence depth temper uncertain readings toward 50; confidence remains a separate reliability measure.

Latest source headline Chemours' Q2 Earnings & Revenues Lag Estimates on Lower Volumes finance.yahoo.com · 11 Aug 2026 12:10

What supports the score

Direct evidence

11 current stories are mapped specifically to ALI1.

Source breadth

The read spans 7 publishers rather than depending on one outlet.

What limits the score

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.226.

Confidence

Evidence confidence is 29/100, below the threshold for a firm classification.

49/100
News scoreEarly balanced news score
29/100
Confidencethin evidence
100%/100
Company news11 company stories
78/100
Story agreement22/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
16 Jul: 1 stories22 Jul: 1 stories23 Jul: 1 stories25 Jul: 1 stories29 Jul: 1 stories02 Aug: 2 stories04 Aug: 1 stories06 Aug: 1 stories10 Aug: 1 stories11 Aug: 1 stories 16 Jul: tone 50, 1 stories22 Jul: tone 50, 1 stories23 Jul: tone 50, 1 stories25 Jul: tone 50, 1 stories29 Jul: tone 50, 1 stories02 Aug: tone 50, 2 stories04 Aug: tone 50, 1 stories06 Aug: tone 50, 1 stories10 Aug: tone 74, 1 stories11 Aug: tone 28, 1 stories 95505
15 Jul30 Jul13 Aug
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence5
0.226 after freshness weighting
Source breadth100
7 independent publishers
Company relevance100
share tied directly to this company
Freshness61
recency-weighted evidence
Agreement78
how closely stories agree
Publisher mix6
less reliance on one publisher

Price and news history

News score and weekly price over 26 weeks

Early company-news score

Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.

One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb 2026: close 11.64, indexed 100.020 Feb 2026: close 12.36, indexed 106.227 Feb 2026: close 15.28, indexed 131.306 Mar 2026: close 16.16, indexed 138.813 Mar 2026: close 16.8, indexed 144.320 Mar 2026: close 14.32, indexed 123.027 Mar 2026: close 13.28, indexed 114.103 Apr 2026: close 13.36, indexed 114.810 Apr 2026: close 15.21, indexed 130.717 Apr 2026: close 20.45, indexed 175.724 Apr 2026: close 18.64, indexed 160.101 May 2026: close 17.61, indexed 151.208 May 2026: close 16.26, indexed 139.715 May 2026: close 15.19, indexed 130.522 May 2026: close 15.92, indexed 136.829 May 2026: close 17.51, indexed 150.405 Jun 2026: close 14.51, indexed 124.712 Jun 2026: close 15.29, indexed 131.419 Jun 2026: close 16.5, indexed 141.726 Jun 2026: close 14.55, indexed 125.003 Jul 2026: close 14.32, indexed 123.110 Jul 2026: close 13.89, indexed 119.417 Jul 2026: close 11.7, indexed 100.524 Jul 2026: close 12.1, indexed 103.931 Jul 2026: close 9.92, indexed 85.307 Aug 2026: close 12.04, indexed 103.4 26 Jun 2026: news score 50, close 14.55, 2 stories5003 Jul 2026: news score 50, close 14.32, 5 stories5010 Jul 2026: news score 50, close 13.89, 5 stories5017 Jul 2026: news score 50, close 11.7, 6 stories5024 Jul 2026: news score 50, close 12.1, 6 stories5031 Jul 2026: news score 50, close 9.92, 6 stories5007 Aug 2026: news score 50, close 12.04, 9 stories50
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+3.4%latest close 12.04
News score change+0first to latest comparable week
One-week response+21.3%Price confirming higher
Fair-value position+179.7%Materially above fair value
WeekNews scoreCloseWeekly move
07 Aug 202650EUR 12.04+21.3%
31 Jul 202650EUR 9.92-17.9%
24 Jul 202650EUR 12.1+3.4%
17 Jul 202650EUR 11.7-15.8%
10 Jul 202650EUR 13.89-3.0%
03 Jul 202650EUR 14.32-1.6%
26 Jun 202650EUR 14.55-11.8%
Provisional evidence

News subjects

What is shaping the score

Market update
Market update509 stories · 82%
Earnings472 stories · 18%

Source mix

Where the evidence comes from

6/100 independence
AD HOC NEWS503 stories · 27%
finance.yahoo.com472 stories · 18%
MarketBeat502 stories · 18%
Discovery Alert501 stories · 9%
news.financial501 stories · 9%
Business Wire501 stories · 9%
Kalkine Media501 stories · 9%

Recurring subjects

Subjects appearing most often

Current evidence
Total Revenue1R D1Medical Dermatology1Free Cash Flow1Financials1Earnings Per Share1Earnings1Drug Discovery1Consensus Estimate1Collaboration1

Earlier readings

How the score has changed

16 comparable readings · 53 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move-750 to 43 · Weakening
Observed range42–5150 is the neutral baseline
Evidence depth11stories at latest stored reading · +10
Confidence31/100Provisional · +6
21 Jun50 neutral13 Aug 18:28
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
13 Aug 18:2843+131/100 (-4)11 (0)Provisional
11 Aug 23:5942-935/100 (+7)11 (+1)Provisional
10 Aug 23:5951+128/100 (+6)10 (+1)Provisional
06 Aug 23:5950+022/100 (-3)9 (+1)Provisional
04 Aug 23:5950+025/100 (-2)8 (+1)Provisional
02 Aug 23:5950+027/100 (+3)7 (0)Provisional
29 Jul 23:5950+024/100 (+1)7 (0)Provisional
25 Jul 23:5950+023/100 (-2)7 (+1)Provisional

Source headlines

The news behind the score

Showing 1-11 of 11

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#128Tone
finance.yahoo.comDirect company coverage

Chemours' Q2 Earnings & Revenues Lag Estimates on Lower Volumes

The Chemours Company CC reported a net loss of $274 million or a loss of $1.81 per share for the second quarter of 2026. This compares favorably with the year-ago quarter's net loss of $380 million or a loss of $2.53 per share. Barring one-time items, earnings were 42 cents per share, which missed the Zacks Consensus Estimate of 43 cents by roughly 2.3%. Adjusted earnings also declined from 61 cents per share in the year-ago quarter. The company reported second-quarter net sales of $1,591 million, reflecting a 1% decrease from the previous-year quarter. The figure missed the Zacks Consensus Es

ChemicalsConsensus EstimateEarningsEarnings Per ShareFinancialsFree Cash Flow
Published
11 Aug 2026 12:10
News subject
Earnings
Why this score
Missed expectations, Improving financial comparison, Deteriorating financial comparison, Margin expansion
How it is used
Direct company coverage
Weighted influence
High · 56% · 2.3d old
Duplicates
1 consolidated
#274Tone
finance.yahoo.comDirect company coverage

Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology

The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology. CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland China. The agreement further expands Almirall's innovation footprint in China, based on the compan

CollaborationDrug DiscoveryMedical DermatologyR DTotal Revenue
Published
10 Aug 2026 06:00
News subject
Earnings
Why this score
Positive financial language
How it is used
Direct company coverage
Weighted influence
High · 40.7% · 3.5d old
Duplicates
1 consolidated
#450Tone
MarketBeatDirect company coverageScored from headlineSource lookup

Almonty Industries (NASDAQ:ALM) Stock Price Up 13.3% - Here's Why

Published
04 Aug 2026 16:59
News subject
Market update
Why this score
No clear positive or negative phrase
How it is used
Direct company coverage
Weighted influence
Low · 0.9% · 9.1d old
Duplicates
1 consolidated
#850Tone
Discovery AlertDirect company coverageScored from headlineSource lookup

Almonty Delists from ASX and TSX: Key Investor Dates 2026

Published
25 Jul 2026 01:31
News subject
Market update
Why this score
No clear positive or negative phrase
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 19.7d old
Duplicates
1 consolidated
#1050Tone
Business WireDirect company coverageScored from headlineSource lookup

Almonty to Voluntarily Delist From TSX

Published
22 Jul 2026 06:32
News subject
Market update
Why this score
No clear positive or negative phrase
How it is used
Direct company coverage
Weighted influence
Low · <0.1% · 22.5d old
Duplicates
1 consolidated

Earlier company news

ALI1 news archive

Showing 1-5 of 5 stored headlines

Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above. Where an early legacy import did not retain its canonical URL, the headline links to an exact publisher-aware source lookup instead of inventing an article address.

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context